- Home
- ALEX vs TVTX Comparison
ALEX vs TVTX Comparison
Compare ALEX & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALEX
- TVTX
- Stock Information
- Founded
- ALEX 1870
- TVTX 2008
- Country
- ALEX United States
- TVTX United States
- Employees
- ALEX N/A
- TVTX N/A
- Industry
- ALEX Real Estate Investment Trusts
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- ALEX Real Estate
- TVTX Health Care
- Exchange
- ALEX Nasdaq
- TVTX Nasdaq
- Market Cap
- ALEX 1.3B
- TVTX 1.4B
- IPO Year
- ALEX N/A
- TVTX N/A
- Fundamental
- Price
- ALEX $18.18
- TVTX $15.01
- Analyst Decision
- ALEX Buy
- TVTX Strong Buy
- Analyst Count
- ALEX 3
- TVTX 16
- Target Price
- ALEX $23.00
- TVTX $33.33
- AVG Volume (30 Days)
- ALEX 378.3K
- TVTX 1.5M
- Earning Date
- ALEX 07-24-2025
- TVTX 07-31-2025
- Dividend Yield
- ALEX 4.95%
- TVTX N/A
- EPS Growth
- ALEX 38.72
- TVTX N/A
- EPS
- ALEX 0.85
- TVTX N/A
- Revenue
- ALEX $236,060,000.00
- TVTX $273,533,000.00
- Revenue This Year
- ALEX N/A
- TVTX $73.84
- Revenue Next Year
- ALEX $2.06
- TVTX $46.72
- P/E Ratio
- ALEX $20.42
- TVTX N/A
- Revenue Growth
- ALEX 6.41
- TVTX 75.65
- 52 Week Low
- ALEX $15.70
- TVTX $7.72
- 52 Week High
- ALEX $20.30
- TVTX $25.29
- Technical
- Relative Strength Index (RSI)
- ALEX 58.66
- TVTX 45.34
- Support Level
- ALEX $17.56
- TVTX $14.36
- Resistance Level
- ALEX $18.20
- TVTX $15.27
- Average True Range (ATR)
- ALEX 0.29
- TVTX 0.61
- MACD
- ALEX -0.01
- TVTX 0.15
- Stochastic Oscillator
- ALEX 96.92
- TVTX 71.13
About ALEX Alexander & Baldwin Inc. REIT Holding Company
Alexander & Baldwin Inc is a Hawaii commercial real estate company. The group owns, operates, and manages million square feet of retail, industrial, and office space in Hawaii. It is a real estate investment trust (REIT) and the owner of grocery and drug-anchored retail centers in the state. It functions through two segments namely Commercial Real Estate and Land Operations. The Commercial Real Estate segment owns and manages retail, industrial spaces, and also urban ground leases in Hawaii, thereby accounting for a majority of the company's revenue. The Land Operations segment actively manages the company's land and real estate-related assets and makes optimum utilization of these assets. Geographically, the activities are carried out across the United States.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.